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 Abstract  Article Information 
In the present study, characterization and antibacterial activity of a glycoside antibiotic 
from fermentation broth of bioactive Streptomyces variabilis PO-178 recovered previously 
from Western Ghat soil of Agumbe, Karnataka, India was investigated. Mass cultivation of 
the strain PO-178 was carried out in Starch casein nitrate broth. The fermentation broth 
was extracted using butanol solvent in a separation funnel. The concentrated butanol 
extract was subjected to chromatographic techniques viz., thin layer and silica gel column 
chromatography for purification of bioactive components. Out of 3 fractions (A, B and C) 
obtained, only one fraction (C) displayed inhibitory activity against Staphylococcus aureus 
and Pseudomonas aeruginosa. The bioactive fraction C was subjected to spectral 
analysis (LC-MS, IR, 1H-NMR and 13C-NMR) in order to determine the structure. On the 
basis result of spectral analysis, the purified fraction was predicted as a glycoside 
antibiotic with molecular weight 514 and molecular formula C24H34O12. The antibiotic 
displayed marked inhibitory activity against S. aureus as revealed by wider zones of 
inhibition and low minimum inhibitory concentration value.  
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INTRODUCTION 
Among various secondary metabolites of microbial 
origin, antibiotics are considered as an important group of 
chemotherapeutic compounds with activity against 
microorganisms. These antibiotics differ in their chemical 
nature, mode of action, possible effect on the animal body 
and spectrum of activity (narrow or broad spectrum). 
Antibiotics are produced by bacteria, fungi and 
actinomycetes. The antibiotic era began with the 
accidental discovery of Penicillin (produced by Penicillium 
notatum) by Alexander Fleming in 1929. Later, Selman 
Waksman discovered Streptomycin from Streptomyces 
griseus in the year 1943. The discovery of antibiotics is 
considered as a turning point in medicine and their 
subsequent use saved countless lives and revolutionized 
the medicine field. However, the use of these wonder 
drugs has been accompanied by the rapid emergence of 
resistant microbes. Methicillin-resistant Staphylococcus 
aureus, multidrug-resistant Streptococcus pneumoniae, 
vancomycin-resistant Enterococcus spp., multidrug 
resistant Acinetobacter baumannii, Klebsiella 
pneumoniae, Escherichia coli, Pseudomonas aeruginosa, 
multidrug-resistant TB are among the most important 
drug-resistant pathogens. A wide range of biochemical 
and physiological mechanisms are involved in the 
development of resistance against antimicrobials. 
Moreover, the ability of pathogens to acquire and transmit 
resistance has made the situation even worst. Hence, 
search for new antimicrobials is a continuous process to 
keep pace with continually evolving pathogens 
(Waksman, 1952; Lenski, 1998; Yoshikawa, 2002; Levy 
and Marshall, 2004; Tenover, 2006; Dzidic et al., 2008; 
Lister et al., 2009; Davies and Davies, 2010). 
 
Actinomycetes (akitino- ray; mykes- fungus) are Gram 
positive bacteria belonging to the order Actinomycetales, 
characterized by the formation of substrate and aerial 
mycelium, presence of spores and a high GC content of 
the DNA. The genus Streptomyces constitute the major 
actinomycete genera. The species of Streptomyces are 
aerobic spore formers possessing DNA rich in GC content 
(69-73%). Streptomyces species are filamentous and form 
extensive branching substrate and aerial mycelia. The 
morphological differentiation of Streptomyces results in 
the formation of hyphae that can differentiate into a chain 
of spores. This process is unique among Gram-positives, 
requiring a specialized and coordinated metabolism. 
Streptomyces are ubiquitous in nature and are most 
common in soil. In soil, these contribute significantly to the 
turnover of complex biopolymers. They are known to 
degrade a variety of xenobiotics. These species have 
produced >75% bioactive metabolites having commercial 
importance, notably antibiotics. The metabolites produced 
from Streptomycetes have found medicinal (human and 
veterinary) and agricultural importance. Streptomyces 
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species are shown to produce a wide array of chemically 
diverse bioactive agents such as antibacterial agents, 
antifungal agents, antiviral drugs, antiparasitic agents, 
plant growth promoters, antioxidants, antitumor agents, 
herbicides, pesticides and other pharmacologically 
important agents (Anderson and Wellington, 2001; Kokare 
et al., 2004; Yadav et al., 2008; Kekuda et al., 2010a; 
Priya et al., 2012; Procopio et al., 2012; Manasa et al., 
2014). The strain Streptomyces variabilis PO-178 used in 
the present study was isolated from isolated from a 
rhizosphere soil of Western Ghat region of Agumbe, 
Shivamogga district, Karnataka, India. In our previous 
studies, the strain PO-178 displayed several bioactivities 
(Kekuda et al., 2013; Kekuda and Onkarappa, 2014; 
Kekuda and Onkarappa, 2015). In continuation of our 
previous studies, in the present study, we describe 
characterization and antibacterial activity of a glycoside 
antibiotic obtained from butanol extract S. variabilis PO-
178.    
 
MATERIALS AND METHODS 
Isolation and Characterization of S. variabilis PO-178 
The strain PO-178 was isolated previously from a 
rhizosphere soil sample of Agumbe, Western Ghat region 
of Shivamogga district, Karnataka, India by serial dilution-
plating method (on Starch casein nitrate agar). The 
characterization of the isolate was done by morphological, 
microscopic, biochemical and 16S rDNA sequencing 
studies (Kekuda and Onkarappa, 2015). 
 
 
Figure 1: Culture and spore arrangement of S. variabilis PO-178 (Kekuda and Onkarappa, 2015) 
 
Fermentation  
The well sporulated culture of strain PO-178 was 
aseptically inoculated into conical flasks containing sterile 
Starch casein nitrate broth. The flasks were incubated 
aerobically at 28
o
C for 10 days. After incubation, culture 
broth was filtered through Whatman No. 1 filter paper and 
the culture filtrate obtained was centrifuged (10000rpm). 
The supernatant was extracted in a separation funnel 
using butanol and concentrated in rotary evaporator 
(Kekuda and Onkarappa, 2015).  
 
Recovery of the Bioactive Metabolite from Butanol 
Extract 
The brown colored crude extract obtained was 
subjected for isolation and purification of components by 
analytical methods namely Thin Layer Chromatography 
(TLC) and Column chromatography. The butanol extract 
was spotted on TLC plate and developed with solvent 
systems that consisted of different ratios of ethanol:water, 
methanol:water and ethanol:methanol:water. The 
chromatograms were allowed to air dry and were exposed 
to iodine vapours for the detection of resolved 
components. The recovery of bioactive principle from the 
butanol extract was carried out by Column 
chromatography. Column chromatography was performed 
by employing silica gel 60-120 mesh size of 
chromatography grade (Himedia, Mumbai) in a sintered 
filter column (40x4cm). The column was treated with 
chromic acid followed by water and then rinsed with 
acetone. The column was packed well with activated silica 
using chloroform solvent. The butanol extract of isolate 
PO-178 was loaded at the top of the column. The column 
was eluted using solvent systems. Fractions were 
collected at regular intervals, loaded on TLC plates, 
developed with solvent system and observed for spots in 
iodine chamber. The fractions exhibiting same Rf values 
were pooled and the solvent was evaporated at 40°C to 
get concentrated fraction (Augustine et al., 2005; Rahman 
and Humainy, 2011). Three pure fractions (A, B and C) 
were obtained. 
 
Antibacterial activity of Pure Fractions  
The fractions A, B and C (0.5 and 1.0mg/ml of 
dimethyl sulfoxide [DMSO]) were screened for 
antibacterial activity against Staphylococcus aureus and 
Pseudomonas aeruginosa by Agar well diffusion method. 
Streptomycin was used as reference standard (Kekuda 
and Onkarappa, 2015). Only fraction C (68mg yield) 
displayed inhibitory activity against test bacteria. Hence, 
fraction C was subjected to minimum inhibitory 
concentration (MIC) determination (Kosanic and 
Rankovic, 2010) and elucidation of structure.   
 
Spectral Analysis and Structural Elucidation of 
Bioactive Compound 
The purity and molecular weight of the bioactive 
fraction C (PK-06) was assessed by Liquid 
Chromatography and Mass Spectrum (LCMS 2010, 
Shimadzu, Japan). The fraction C was dissolved in 
methanol and 5μl of the compound was injected into a C-
18 HPLC column with methanol: water (90:10) at a flow 
rate of 0.2ml/min. The UV-VIS detection was carried out. 
Mass spectral studies were carried out by atmospheric 
pressure chemical ionization probe (APCI) for the analysis 
of nonpolar compounds and Electron Spray Ionization 
probe (ESI) for the analysis of polar compounds. The Infra 
red (IR) spectra was recorded on Shimadzu IR - model. 
The fraction C was scanned from 400-4000cm/range. The 
fraction was dissolved in DMSO and was subjected to 
1
H-
NMR (Nuclear Magnetic Resonance) and 
13
C-NMR in 
Bruker BioSpin model. The nature and structure of the 
bioactive fraction was elucidated by analyzing the 
chromatograms and spectra with pertinent literature. 
 
RESULTS  
Spectral Analysis and Structural Elucidation of 
Purified Bioactive Compound 
The LC-MS (Figure 2) revealed that the compound is 
pure as the LC chromatogram showed a single prominent 
peak. The peak observed at Mass Speak 513 confirms 
the molecular weight of the compound i.e. 514 (negative 
mode).
 




Figure 2: LC-MS of the purified compound 
 
Figure 3 shows the IR spectra of the purified 





indicated the presence of hydroxyl 
(-OH) and carbonyl   (-C=O) groups respectively.  
 
 
Figure 3: IR spectra of purified compound 
 
 




H-NMR spectra of purified compound is shown in 
Figure 4. The singlet appeared at the region of 9.6δ value 
is confirmed the presence of aldehyde proton. The singlet 
appeared at the region of 5.1δ value is for –OH group 
present in α position to aldehyde group. The two doublets 
for –CH=CH appeared at the region of 5.4 to 5.6δ values. 
The 6 singlets for 6 –OH groups appeared at the region of 
4.2 to 4.9δ values. The singlet appeared at the region of 
1.1 δ value is for – CH3 proton and the multiplets present 
at the region of 2.7 to 3.8 is for –CH and –CH2 protons 
and the multiplets present at the region of 2.7 to 3.8 is for 




H-NMR spectra of purified compound 
 
13
C-NMR spectra of purified compound is shown in 
Figure 5. The peak appeared at the region of 158δ value 
is confirmed the presence of aldehyde carbon. The peak 
appeared at 105δ value confirmed the presence of furon 
ring carbon. The peak appeared at 82-94δ value 
confirmed the presence of –C-OH carbons. The peak 
appeared at 32δ value confirms the presence of aliphatic 





C-NMR of purified compound 
 
On the basis of obtained spectral data, the purified 
compound can be predicted as a glycoside as it contains 




carbaldehyde. The molecular formula of the compound is 
C24H34O12 (Figure 6). 
 





Figure 6: Structure of purified compound (Fraction C) 
 
Antibacterial Activity of Pure Compound 
The purified compound was found effective against 
bacteria (Table 1 and Figure 7). Both Streptomycin and 
the compound were effective in inhibiting the growth of S. 
aureus and P. aeruginosa in a dose dependent manner. 
Among bacteria, S. aureus was inhibited to higher extent. 
Inhibition caused by Streptomycin was marked when 
compared to purified compound. The MIC of compound 
was found to be 62.5μg/ml and 15.625μg/ml for P. 
aeruginosa and S. aureus respectively. 
 
Table 1: Antibacterial activity of purified compound 
 
Test bacteria 
Zone of inhibition in cm (Mean±SD) 
Purified compound Streptomycin 
0.5mg/ml 1.0mg/ml 0.5mg/ml 1.0mg/ml 
S. aureus 2.70±0.00 2.80±0.00 3.25±0.10 3.80±0.00 
P.aeruginosa 1.85±0.01 2.10±0.00 2.33±0.05 2.80±0.00 
 
 




Western Ghats of India represent one of the 
biodiversity hotspots in the world. The Western Ghats 
harbor diverse flora and fauna. Agumbe is one of the most 
scenic places on the Western Ghats of Shivamogga 
district, Karnataka, India. Studies on bioactivities of 
actinomycetes isolated from Agumbe region of Western 
Ghats of Karnataka have been carried out.  Bioactivities 
such as antimicrobial, antioxidant, enzyme inhibitory, 
cytotoxic, anthelmintic, insecticidal, analgesic, anti-
inflammatory and antipyretic activity of Streptomyces 
species isolated from soils of Agumbe, Karnataka, India 
have been investigated (Kekuda et al., 2010b; Kekuda et 
al., 2012; Gautham et al., 2012; Gautham et al., 2013; 
Kekuda and Onkarappa, 2015). The bioactive strain S. 
variabilis PO-178 used in this study was isolated from a 
soil sample of Agumbe, Karnataka, India. The extracts 
obtained from this strain were shown to exhibit 
bioactivities of such as antimicrobial, antioxidant, 
insecticidal, anthelmintic, enzyme inhibitory (amylase and 
pancreatic lipase) activity and pharmacological activities 
namely analgesic, anti-inflammatory, antipyretic and CNS 
depressant activity (Kekuda et al., 2013; Kekuda and 
Onkarappa, 2014; Kekuda and Onkarappa, 2015).  
 
The identification of active compounds from 
fermentation medium is one of the most complicated, 
labour intensive, time consuming step of the screening 
protocols. However, the great progress in the 
chromatographic isolation methods and spectroscopic 
identification techniques are more or less satisfying the 
requirements of the modern screening programs. In the 
last decades using MS, NMR and X-Ray methods it 
became to solve the structure in minimum quantities of 
products. The structure determination of a new 
compound, isolated perhaps only on mg scale is a 
relatively easy task (Berdy, 2005). In the present study, an 
active compound was isolated by silica gel column 
chromatography from the butanol extract of the 
fermentation broth of S. variabilis PO-178. The spectral 





NMR. On the basis of spectral data, the structure of the 
bioactive agent was elucidated. The compound was found 
to be a glycoside having molecular weight of 514. 
 
A large number of antibiotics are glycosides. In 
numerous cases, the glycosidic residues are crucial for 
their activity, but sometimes glycosylation only improves 
the pharmacokinetic parameters. Recently, the 
development of carbohydrate-based antibiotics has been 
suggested as a new approach to the problem of antibiotic 
resistance (Ritter and Wong, 2001). Glycoside antibiotics 
have shown to be effective in inhibiting microorganisms. 
Singh et al. (2000) showed antimicrobial activity of 
Saccharomicins, novel heptadecaglycoside antibiotics 
from Saccharothrix espanaensis. A disaccharide 
glycoside molecule α-L-sorbofuranose (3 → 2)-β-D-
altrofuranose was isolated from the aqueous fraction of 
culture filtrate of Streptomyces sp. strain JJ45. The 
molecule was effective against Xanthomonas sp. (Kang et 
al., 2009). In another study, Gautham (2012) isolated an 
antibiotic active against bacteria and molds from butanol 
extract of Streptomyces fradiae GOS01. The antibiotic 
was found to be xyloglucose disaccharide molecule. A 
new polyketide glycoside isolated from Streptomyces sp. 
QD01-2 was shown to exhibit marked antimicrobial 
activity (Hou et al., 2012). In the present study, the 
glycoside antibiotic isolated from the actinomycete strain 
S. variabilis PO-178 was found to display marked 
antibacterial activity against Gram positive and Gram 
negative bacteria. The antibiotic displayed marked activity 
against S. aureus when compared to P. aeruginosa. The 
low susceptibility of P. aeruginosa to the antibiotic might 
be ascribed to the presence of outer membrane which 
may act as an additional barrier to the entry of antibiotic 
(Manasa et al., 2014). In a previous study, Nakagawa et 
al. (1990) isolated a depsipeptide antibiotic Variapeptin 
from the culture identified as S. variabilis. The antibiotic 
was active against Gram positive bacteria and showed 
cytotoxicity against mammalian cell lines.  
 
CONCLUSIONS 
The present study showed the potential of Western 
Ghat actinomycete S. variabilis PO-178 to produce a 
glycoside antibiotic active against Gram positive and 
Gram negative bacteria. The antibiotic was more effective 
against S. aureus as evidenced by wider zones of 
inhibition and lower MIC value. Further in vivo studies are 
under progress to evaluate the safety margins for the 
antibiotic.  
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